Merck KGaA CEO on Retaining Talent

The transcript discusses a company's three main divisions: life science, biopharma, and electronics, highlighting their performance in 2022. It covers the company's acquisition strategy, financial position, and growth ambitions. The conversation shifts to the future of work, emphasizing a shift in hiring practices from experience to attitude, and the importance of building a high-impact culture.

Which division was the main growth driver for the company in Q3 2022?

• Biopharma

• Life Science

• Healthcare

• Electronics

What is the company's mid-term ambition for 2025?

• To become the largest electronics provider

• To deliver 25 billion in revenue

• To acquire 10 new companies

• To reduce operational costs by 50%

What is the company's approach to acquisitions?

• Avoid acquisitions at all costs

• Acquire only in the electronics sector

• Focus solely on biopharma acquisitions

• Keep optionality and consider acquisitions to accelerate growth

Which market is considered highly predictable and stable by the company?

• Retail

• Automotive

• Life Science

• Electronics

What is the company's new focus in hiring practices?

• Hiring based on experience

• Hiring based on age

• Hiring based on location

• Hiring based on attitude

What has become a key dimension of the company's enterprise strategy?

• Increasing product lines

• Expanding globally

• Building a high-impact culture

• Reducing costs

What is considered one of the most difficult decisions for leaders in the company?

• Product development decisions

• Capital allocation decisions

• Marketing strategy decisions

• People decisions